Gene · 5740
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma. | Front Oncol | 2022 | 36324576 | PubTator, text mining | PubMed |
| The physiological and pharmacological roles of prostaglandins in hair growth. | Korean J Physiol Pharmacol | 2022 | 36302616 | PubTator, text mining | PubMed |
| Recent Advances in the Treatment of Pulmonary Arterial Hypertension. | Pharmaceuticals (Basel) | 2022 | 36297387 | PubTator, text mining | PubMed |
| Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes. | Pharmaceuticals (Basel) | 2022 | 36297354 | PubTator, text mining | PubMed |
| Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progression. | Gastro Hep Adv | 2022 | 36277993 | PubTator, text mining | PubMed |
| From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. | Int J Chron Obstruct Pulmon Dis | 2022 | 36274992 | PubTator, text mining | PubMed |
| Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer. | Front Oncol | 2022 | 36267966 | PubTator, text mining | PubMed |
| The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer. | Dis Markers | 2022 | 36199822 | PubTator, text mining | PubMed |
| Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options. | Biomedicines | 2022 | 36140374 | PubTator, text mining | PubMed |
| Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy. | J Oncol | 2022 | 36131793 | PubTator, text mining | PubMed |
| Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment. | Biomed Res Int | 2022 | 36110123 | PubTator, text mining | PubMed |
| Posttraumatic Growth and Its Measurement: A Closer Look at the PTGI's Psychometric Properties and Structure. | Front Psychol | 2022 | 36092073 | PubTator, text mining | PubMed |
| Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors. | Animals (Basel) | 2022 | 36077955 | PubTator, text mining | PubMed |
| Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review. | Investig Clin Urol | 2022 | 36067994 | PubTator, text mining | PubMed |
| The long-term impact of the earthquake on substance use. | Int J Emerg Med | 2022 | 36064323 | PubTator, text mining | PubMed |
| Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis. | Dis Markers | 2022 | 36061357 | PubTator, text mining | PubMed |
| Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment. | Front Oncol | 2022 | 36059672 | PubTator, text mining | PubMed |
| A structural basis for the functional differences between the cytosolic and plastid phosphoglucose isomerase isozymes. | PLoS One | 2022 | 36048814 | PubTator, text mining | PubMed |
| New progress in diagnosis and treatment of pulmonary arterial hypertension. | J Cardiothorac Surg | 2022 | 36038916 | PubTator, text mining | PubMed |
| Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease. | Cardiovasc Ther | 2022 | 36035865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5740/papers?page=12